BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20077027)

  • 1. Stability analysis of a simplified yet complete model for chronic myelogenous leukemia.
    Doumic-Jauffret M; Kim PS; Perthame B
    Bull Math Biol; 2010 Oct; 72(7):1732-59. PubMed ID: 20077027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A PDE model for imatinib-treated chronic myelogenous leukemia.
    Kim PS; Lee PP; Levy D
    Bull Math Biol; 2008 Oct; 70(7):1994-2016. PubMed ID: 18663536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling imatinib-treated chronic myelogenous leukemia: reducing the complexity of agent-based models.
    Kim PS; Lee PP; Levy D
    Bull Math Biol; 2008 Apr; 70(3):728-44. PubMed ID: 18060460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An "age"-structured model of hematopoietic stem cell organization with application to chronic myeloid leukemia.
    Roeder I; Herberg M; Horn M
    Bull Math Biol; 2009 Apr; 71(3):602-26. PubMed ID: 19101772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical modeling of genesis and treatment of chronic myeloid leukemia.
    Horn M; Loeffler M; Roeder I
    Cells Tissues Organs; 2008; 188(1-2):236-47. PubMed ID: 18303243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical model of granulocytopoiesis and chronic myelogenous leukemia.
    Fokas AS; Keller JB; Clarkson BD
    Cancer Res; 1991 Apr; 51(8):2084-91. PubMed ID: 2009527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells: lessons from leukemia.
    Wang JC; Dick JE
    Trends Cell Biol; 2005 Sep; 15(9):494-501. PubMed ID: 16084092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment effects in chronic myeloid leukemia.
    Besse A; Lepoutre T; Bernard S
    J Math Biol; 2017 Sep; 75(3):733-758. PubMed ID: 28124077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mathematical model of hematopoiesis--I. Periodic chronic myelogenous leukemia.
    Colijn C; Mackey MC
    J Theor Biol; 2005 Nov; 237(2):117-32. PubMed ID: 15975596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical and numerical analysis for a model of growing metastatic tumors.
    Barbolosi D; Benabdallah A; Hubert F; Verga F
    Math Biosci; 2009 Mar; 218(1):1-14. PubMed ID: 19121638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical models of cancer stem cells.
    Michor F
    J Clin Oncol; 2008 Jun; 26(17):2854-61. PubMed ID: 18539964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blasts from the past: new lessons in stem cell biology from chronic myelogenous leukemia.
    Huntly BJ; Gilliland DG
    Cancer Cell; 2004 Sep; 6(3):199-201. PubMed ID: 15380509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative approaches to analyzing imatinib-treated chronic myeloid leukemia.
    Michor F
    Trends Pharmacol Sci; 2007 May; 28(5):197-9. PubMed ID: 17412430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myeloid leukemia stem cells: now on the run.
    Goldman JM
    J Clin Oncol; 2009 Jan; 27(2):313-4. PubMed ID: 19064963
    [No Abstract]   [Full Text] [Related]  

  • 16. The fundamental prevalence of chronic myeloid leukemia-generating clonogenic cells in the light of the neutrality theory of evolution.
    Jankovic GM; Pavlovic M; Vukomanovic DJ; Colovic MD; Lazarevic V
    Blood Cells Mol Dis; 2001; 27(5):913-7. PubMed ID: 11783955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
    Schultheis B; Pasternak G; Hehlmann R
    Folia Biol (Praha); 2000; 46(6):256-63. PubMed ID: 11140859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An optimal dynamic inversion-based neuro-adaptive approach for treatment of chronic myelogenous leukemia.
    Padhi R; Kothari M
    Comput Methods Programs Biomed; 2007 Sep; 87(3):208-24. PubMed ID: 17618012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myeloid leukemia blast crisis arises from progenitors.
    Michor F
    Stem Cells; 2007 May; 25(5):1114-8. PubMed ID: 17218393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
    Williams RT; Sherr CJ
    Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.